Fundamental mechanisms of apoptosis and phospholipid asymmetry
细胞凋亡和磷脂不对称的基本机制
基本信息
- 批准号:10084175
- 负责人:
- 金额:$ 2.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-01 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAnimalsApoptosisAutoimmune DiseasesBiochemicalBiologicalBiological ProcessBiophysicsCancer EtiologyCaspaseCell physiologyCellsDefectDevelopmentEmbryonic DevelopmentEventExcisionGenesHumanInheritedLipidsMalignant NeoplasmsMembraneMitochondriaMitochondrial DiseasesMolecularMolecular GeneticsNeurodegenerative DisordersNormal CellPathologicPathway interactionsPhospholipidsPhysiologicalProcessRoleSignal PathwayWorkfitnessfunctional genomicshuman diseasenew therapeutic targetnovelreverse genetics
项目摘要
Project summary
Programmed cell death, phospholipid asymmetry, and paternal mitochondrial elimination are three vitally
important, distinct, and interconnected biological processes essential for normal cell functions and animal
development. Defects in these processes can cause various pathological conditions and human disease,
including neurodegenerative disease, autoimmune disorders, various inherited human mitochondrial disease,
and cancer. In this proposed work, we will carry out molecular genetic, reverse genetic, biochemical, cell
biological, biophysical, and functional genomic analyses to decipher basic mechanisms of apoptosis,
phospholipid asymmetry, and paternal mitochondrial elimination during animal development. For the study of
apoptosis, we hope to understand the regulatory mechanisms and signaling pathways that control the release
of mitochondrial apoptogenic factors during apoptosis and identify new targets and downstream pathways of
the cell death protease that execute highly organized cell disassembly and rapid removal of the dying cells. For
the study of phospholipid asymmetry, we plan to identify the molecular components and regulatory
machineries that generate, maintain, and alter phospholipid asymmetry, decipher the functions and roles of
specific phospholipids to a cell, and reveal the physiological and pathological consequences of altered
phospholipid asymmetry to the cell and the animal. For the study of paternal mitochondrial elimination, we will
investigate how and why paternal mitochondria are selectively recognized and targeted for elimination, the
paternal and maternal factors and machineries required of this uniparental inheritance process, and the
physiological significance of paternal mitochondrial elimination to embryo development and organismal fitness.
These studies should reveal novel mechanisms, pathways, and genes that control these three fundamental
biological processes, and ultimately, provide new targets, ideas, and strategies to facilitate treatment of
numerous human diseases caused by abnormalities in these three important processes.
项目摘要
细胞程序性死亡、磷脂不对称和父源性线粒体消除是三个重要的
重要的,独特的和相互关联的生物过程,对正常细胞功能和动物
发展这些过程中的缺陷可导致各种病理状况和人类疾病,
包括神经变性疾病、自身免疫性疾病、各种遗传性人线粒体疾病
和癌症在这项拟议的工作中,我们将进行分子遗传学,反向遗传学,生物化学,细胞
生物学、生物物理学和功能基因组分析,以破译细胞凋亡的基本机制,
磷脂不对称性和动物发育过程中父系线粒体的消除。为研究
细胞凋亡,我们希望了解调控机制和信号通路,控制释放
线粒体促凋亡因子在凋亡过程中的作用,并确定新的靶点和下游途径,
该细胞死亡蛋白酶执行高度有组织的细胞分解和快速去除垂死细胞。为
磷脂不对称性的研究,我们计划确定分子组成和调节
产生、维持和改变磷脂不对称性的机制,
具体磷脂的细胞,并揭示生理和病理后果的改变
磷脂不对称性对细胞和动物的影响。对于父系线粒体消除的研究,我们将
研究如何以及为什么选择性地识别和消除父系线粒体,
父亲和母亲的因素和机器所需的这一单亲遗传过程,和
父系线粒体消除对胚胎发育和生物体适应性的生理意义。
这些研究应该揭示新的机制,途径和基因,控制这三个基本的
生物过程,并最终提供新的目标,想法和策略,以促进治疗
这三个重要过程的异常导致了人类的许多疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DING XUE其他文献
DING XUE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DING XUE', 18)}}的其他基金
Fundamental mechanisms of apoptosis and phospholipid asymmetry
细胞凋亡和磷脂不对称的基本机制
- 批准号:
9071837 - 财政年份:2016
- 资助金额:
$ 2.1万 - 项目类别:
Fundamental mechanisms of paternal mitochondrial eliminationand radiation-induced bystander effects
父本线粒体消除和辐射诱导的旁观者效应的基本机制
- 批准号:
10631083 - 财政年份:2016
- 资助金额:
$ 2.1万 - 项目类别:
Fundamental mechanisms of paternal mitochondrial eliminationand radiation-induced bystander effects
父本线粒体消除和辐射诱导的旁观者效应的基本机制
- 批准号:
10582377 - 财政年份:2016
- 资助金额:
$ 2.1万 - 项目类别:
Fundamental mechanisms of paternal mitochondrial eliminationand radiation-induced bystander effects
父本线粒体消除和辐射诱导的旁观者效应的基本机制
- 批准号:
10413845 - 财政年份:2016
- 资助金额:
$ 2.1万 - 项目类别:
Fundamental mechanisms of paternal mitochondrial eliminationand radiation-induced bystander effects
父本线粒体消除和辐射诱导的旁观者效应的基本机制
- 批准号:
10799384 - 财政年份:2016
- 资助金额:
$ 2.1万 - 项目类别:
Fundamental mechanisms of paternal mitochondrial elimination and radiation-induced bystander effects
父系线粒体消除和辐射引起的旁观者效应的基本机制
- 批准号:
10175605 - 财政年份:2016
- 资助金额:
$ 2.1万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 2.1万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 2.1万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 2.1万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 2.1万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 2.1万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 2.1万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 2.1万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 2.1万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 2.1万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 2.1万 - 项目类别: